208 related articles for article (PubMed ID: 32545414)
1. RNA Binding Proteins as Drivers and Therapeutic Target Candidates in Pancreatic Ductal Adenocarcinoma.
Glaß M; Michl P; Hüttelmaier AS
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32545414
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Post-transcriptional Gene Regulation in Pancreatic Cancer Cells: Studying RNA Binding Proteins and Their mRNA Targets.
Jain A; Brown SZ; Thomsett HL; Londin E; Brody JR
Methods Mol Biol; 2019; 1882():239-252. PubMed ID: 30378060
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of LincRNAs in Classical and Basal-Like Subtypes of Pancreatic Cancer.
Glaß M; Dorn A; Hüttelmaier S; Haemmerle M; Gutschner T
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32727085
[TBL] [Abstract][Full Text] [Related]
4. Peptidase inhibitor 16 promotes proliferation of pancreatic ductal adenocarcinoma cells through OASL signaling.
Chen Q; Jiang LY; Cao C; Liu FY; Li DR; Wu PF; Jiang KR
Mol Carcinog; 2024 May; 63(5):938-950. PubMed ID: 38353288
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor 2 mRNA binding protein 2 promotes aerobic glycolysis and cell proliferation in pancreatic ductal adenocarcinoma via stabilizing GLUT1 mRNA.
Huang S; Wu Z; Cheng Y; Wei W; Hao L
Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):743-752. PubMed ID: 31089713
[TBL] [Abstract][Full Text] [Related]
6. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
Zhou J; Hui X; Mao Y; Fan L
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
[TBL] [Abstract][Full Text] [Related]
8. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS.
Xie F; Li C; Zhang X; Peng W; Wen T
Biomed Pharmacother; 2019 Nov; 119():109424. PubMed ID: 31521891
[TBL] [Abstract][Full Text] [Related]
9. Integrated genomic, transcriptomic, and RNA-interference analysis of genes in somatic copy number gains in pancreatic ductal adenocarcinoma.
Samuel N; Sayad A; Wilson G; Lemire M; Brown KR; Muthuswamy L; Hudson TJ; Moffat J
Pancreas; 2013 Aug; 42(6):1016-26. PubMed ID: 23851435
[TBL] [Abstract][Full Text] [Related]
10. Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR-625 and miR-892b.
Hao L; Rong W; Bai L; Cui H; Zhang S; Li Y; Chen D; Meng X
J Cell Biochem; 2019 Mar; 120(3):3780-3789. PubMed ID: 30382592
[TBL] [Abstract][Full Text] [Related]
11. Upregulated circular RNA circ_0030235 predicts unfavorable prognosis in pancreatic ductal adenocarcinoma and facilitates cell progression by sponging miR-1253 and miR-1294.
Xu Y; Yao Y; Gao P; Cui Y
Biochem Biophys Res Commun; 2019 Jan; 509(1):138-142. PubMed ID: 30591218
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma.
Janky R; Binda MM; Allemeersch J; Van den Broeck A; Govaere O; Swinnen JV; Roskams T; Aerts S; Topal B
BMC Cancer; 2016 Aug; 16():632. PubMed ID: 27520560
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of the gene expression profiles for protein coding and non-coding RNAs of pancreatic ductal adenocarcinomas.
Gutiérrez ML; Corchete L; Teodosio C; Sarasquete ME; del Mar Abad M; Iglesias M; Esteban C; Sayagues JM; Orfao A; Muñoz-Bellvis L
Oncotarget; 2015 Aug; 6(22):19070-86. PubMed ID: 26053098
[TBL] [Abstract][Full Text] [Related]
14. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
Giulietti M; Occhipinti G; Principato G; Piva F
Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA TP53TG1 promotes pancreatic ductal adenocarcinoma development by acting as a molecular sponge of microRNA-96.
Zhang Y; Yang H; Du Y; Liu P; Zhang J; Li Y; Shen H; Xing L; Xue X; Chen J; Zhang X
Cancer Sci; 2019 Sep; 110(9):2760-2772. PubMed ID: 31325400
[TBL] [Abstract][Full Text] [Related]
16. The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Adenocarcinoma.
Brown SZ; McCarthy GA; Carroll JR; Di Niro R; Pelz C; Jain A; Sutton TL; Holly HD; Nevler A; Schultz CW; McCoy MD; Cozzitorto JA; Jiang W; Yeo CJ; Dixon DA; Sears RC; Brody JR
Mol Cell Biol; 2022 Jul; 42(7):e0001822. PubMed ID: 35703534
[TBL] [Abstract][Full Text] [Related]
17. CircFOXK2 Promotes Growth and Metastasis of Pancreatic Ductal Adenocarcinoma by Complexing with RNA-Binding Proteins and Sponging MiR-942.
Wong CH; Lou UK; Li Y; Chan SL; Tong JH; To KF; Chen Y
Cancer Res; 2020 Jun; 80(11):2138-2149. PubMed ID: 32217695
[TBL] [Abstract][Full Text] [Related]
18. Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment.
Huang Y; Nahar S; Nakagawa A; Fernandez-Barrena MG; Mertz JA; Bryant BM; Adams CE; Mino-Kenudson M; Von Alt KN; Chang K; Conery AR; Hatton C; Sims RJ; Fernandez-Zapico ME; Wang X; Lillemoe KD; Fernández-Del Castillo C; Warshaw AL; Thayer SP; Liss AS
Clin Cancer Res; 2016 Aug; 22(16):4259-70. PubMed ID: 27169995
[TBL] [Abstract][Full Text] [Related]
19. Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer.
Gomes-Filho SM; Dos Santos EO; Bertoldi ERM; Scalabrini LC; Heidrich V; Dazzani B; Levantini E; Reis EM; Bassères DS
Cell Oncol (Dordr); 2020 Jun; 43(3):445-460. PubMed ID: 32193808
[TBL] [Abstract][Full Text] [Related]
20. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
